Coverage
-
November 15, 2022
A Hartford unit is dropping its suit seeking to avoid defending a regenerative medicine company in underlying litigation brought by surgical patients who alleged that they contracted tuberculosis from one of the company's products, the insurer told a Maryland federal court.
1 other articles on this case.
View all »